As more Americans turn to weight loss drugs, the U.S. adult obesity rate​ is declining, according to new survey data from ...

Diabetes has reached an all-time high despite a “statistically meaningful decrease” in the adult obesity rate, Gallup ...

Somehow, it’s becoming even harder to get a GLP-1.

The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using ...

After hitting a record high, the U.S. rate of obesity is falling, as the number of people taking GLP-1 medications rises ...

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...

The obesity rate in the U.S. dropped to 37% this year, representing a notable decrease after reaching a record high of 39.9% ...

The U.S. adult obesity rate, calculated as having a BMI of 30 or higher, has gradually declined to 37% in 2025, dropping from a record high of 39.9% in 2022, according to a survey by the Gallup ...

As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are ...

Gallup reported a "meaningful decrease" in the adult obesity rate, which coincided with an increased uptake of injectable ...

Shared biological, psychological, and social pathways put patients at risk for both, whether obesity or depression occurs ...

Compared to placebo (a sham medication), tirzepatide likely helps adults with obesity lose weight in the medium term (up to 2 years), and this weight reduction is likely to be maintained over the long ...